Autoimmune pancreatitis and diagnostic criteria

Current Immunology Reviews

Volumn 7, Issue 2, 2011, Pages 144-161

  Kawa, Shigeyuki ^a   Fujinaga, Yasunari ^b   Ota, Masao ^b   Hamano, Hideaki ^b   Bahram, Seiamak ^c  

^a SHINSHU UNIVERSITY   (Japan)

^b SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

Autoimmune pancreatitis; IgG4; IgG4 related disease

Indexed keywords

2 DEOXY 2 FLUOROMANNOSE F 18; IMMUNOGLOBULIN G4; PREDNISOLONE;

ARTICLE; AUTOIMMUNE PANCREATITIS; BLOOD CHEMISTRY; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; COUGHING; DIABETES MELLITUS; DRUG DOSE REDUCTION; DYSPNEA; ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPY; HYDRONEPHROSIS; HYPERGAMMAGLOBULINEMIA; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSTRUCTIVE JAUNDICE; PRIORITY JOURNAL; RETROPERITONEAL FIBROSIS; SCLEROSING CHOLANGITIS; SJOEGREN SYNDROME;

EID: 79953859800     PISSN: 15733955     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339511795194866     Document Type: Article

References (204)

1. Yoshida K, Toki F, Takeuchi T, Watanabe S, Shiratori K, Hayashi N. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 1995; 40(7): 1561-8.
2. Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001; 344(10): 732-8.
3. Hamano H, Kawa S, Ochi Y, et al. Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis. Lancet 2002; 359(9315): 1403-4.
4. Ito T, Nakano I, Koyanagi S, et al. Autoimmune pancreatitis as a new clinical entity. Three cases of autoimmune pancreatitis with effective steroid therapy. Dig Dis Sci 1997; 42(7): 1458-68.
5. Okazaki K, Chiba T. Autoimmune related pancreatitis. Gut 2002; 51(1): 1-4.
6. th ed. St Louis: Academic Press 2006; pp. 779-86.
7. Kawaguchi K, Koike M, Tsuruta K, Okamoto A, Tabata I, Fujita N. Lymphoplasmacytic sclerosing pancreatitis with cholangitis: a variant of primary sclerosing cholangitis extensively involving pancreas. Hum Pathol 1991; 22(4): 387-95.
8. Toki F, Kozu T, Oi I, Nakasato T, Suzuki M, Hanyu F. An unusual type of chronic pancreatitis showing diffuse irregular narrowing of the entire main pancreatic duct on ERCP-A report of four cases. Endoscopy 1992; 24(7): 640 [Abstract].
9. Okazaki K, Kawa S, Kamisawa T, et al. Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol 2006; 41(7): 626-31.
10. Ohara H, Nakazawa T, Sano H, et al. Systemic extrapancreatic lesions associated with autoimmune pancreatitis. Pancreas 2005; 31(3): 232-7.
11. Hamano H, Arakura N, Muraki T, Ozaki Y, Kiyosawa K, Kawa S. Prevalence and distribution of extrapancreatic lesions complicating autoimmune pancreatitis. J Gastroenterol 2006; 41(12): 1197-205.
12. Okazaki K, Uchida K, Matsushita M, Takaoka M. How to diagnose autoimmune pancreatitis by the revised Japanese clinical criteria. J Gastroenterol 2007; 42(Suppl 18): 32-8.
13. Kamisawa T, Nakajima H, Egawa N, Funata N, Tsuruta K, Okamoto A. IgG4-related sclerosing disease incorporating sclerosing pancreatitis, cholangitis, sialadenitis and retroperitoneal fibrosis with lymphadenopathy. Pancreatology 2006; 6(1-2): 132-7.
14. van der Vliet HJ, Perenboom RM. Multiple pseudotumors in IgG4-associated multifocal systemic fibrosis. Ann Intern Med 2004; 141(11): 896-7.
15. Sato Y, Notohara K, Kojima M, Takata K, Masaki Y, Yoshino T. IgG4-related disease: Historical overview and pathology of hematological disorders. Pathol Int 2010; 60(4): 247-58.
16. Sugumar A, Kloppel G, Chari ST. Autoimmune pancreatitis: pathologic subtypes and their implications for its diagnosis. Am J Gastroenterol 2009; 104(9): 2308-10.
17. Notohara K, Burgart LJ, Yadav D, Chari S, Smyrk TC. Idiopathic chronic pancreatitis with periductal lymphoplasmacytic infiltration: clinicopathologic features of 35 cases. Am J Surg Pathol 2003; 27(8): 1119-27.
18. Zamboni G, Luttges J, Capelli P, et al. Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch 2004; 445(6): 552-63.
19. Frulloni L, Scattolini C, Falconi M, et al. Autoimmune pancreatitis: differences between the focal and diffuse forms in 87 patients. Am J Gastroenterol 2009; 104(9): 2288-94.
20. Nishimori I, Tamakoshi A, Otsuki M. Prevalence of autoimmune pancreatitis in Japan from a nationwide survey in 2002. J Gastroenterol 2007; 42(Suppl 18): 6-8.
21. Shimosegawa T, Kanno A. Autoimmune pancreatitis in Japan: overview and perspective. J Gastroenterol 2009; 44(6): 503-17.
22. JPS. Diagnostic criteria for autoimmune pancreatitis by the Japan Pancreas Society (in Japanese with English abstract). Suizo 2002; 17: 585-7.
23. Kawa S, Hamano H. Clinical features of autoimmune pancreatitis. J Gastroenterol 2007; 42(Suppl 18): 9-14.
24. Hyodo N, Hyodo T. Ultrasonographic evaluation in patients with autoimmune-related pancreatitis. J Gastroenterol 2003; 38(12): 1155-61.
25. Nishino T, Toki F, Oyama H, et al. Biliary tract involvement in autoimmune pancreatitis. Pancreas 2005; 30(1): 76-82.
26. Nishimori I, Tamakoshi A, Kawa S, et al. Influence of steroid therapy on the course of diabetes mellitus in patients with autoimmune pancreatitis: findings from a nationwide survey in Japan. Pancreas 2006; 32(3): 244-8.
27. Tanaka S, Kobayashi T, Nakanishi K, et al. Corticosteroidresponsive diabetes mellitus associated with autoimmune pancreatitis. Lancet 2000; 356(9233): 910-1.
28. Ito T, Kawabe K, Arita Y, et al. Evaluation of pancreatic endocrine and exocrine function in patients with autoimmune pancreatitis. Pancreas 2007; 34(2): 254-9.
29. Ko SB, Mizuno N, Yatabe Y, et al. Corticosteroids correct aberrant cystic fibrosis transmembrane conductance regulator localization in the duct and regenerate acinar cells in autoimmune pancreatitis. Gastroenterology 2010; 138(5): 1988-96.
30. Fujinaga Y, Kadoya M, Kawa S, et al. Characteristic findings in images of extra-pancreatic lesions associated with autoimmune pancreatitis. Eur J Radiol 2010; 76(2): 228-38.
31. Kamisawa T, Funata N, Hayashi Y, et al. Close relationship between autoimmune pancreatitis and multifocal fibrosclerosis. Gut 2003; 52(5): 683-7.
32. Taniguchi T, Ko M, Seko S, et al. Interstitial pneumonia associated with autoimmune pancreatitis. Gut 2004; 53(5): 770-1.
33. Saegusa H, Momose M, Kawa S, et al. Hilar and pancreatic gallium-67 accumulation is characteristic feature of autoimmune pancreatitis. Pancreas 2003; 27(1): 20-5.
34. Hirano K, Kawabe T, Komatsu Y, et al. High-rate pulmonary involvement in autoimmune pancreatitis. Intern Med J 2006; 36(1): 58-61.
35. Erkelens GW, Vleggaar FP, Lesterhuis W, van Buuren HR, van der Werf SD. Sclerosing pancreato-cholangitis responsive to steroid therapy. Lancet 1999; 354(9172): 43-4.
36. Nakazawa T, Ohara H, Yamada T, et al. Atypical primary sclerosing cholangitis cases associated with unusual pancreatitis. Hepatogastroenterology 2001; 48(39): 625-30.
37. Taguchi M, Kihara Y, Nagashio Y, Yamamoto M, Otsuki M, Harada M. Decreased production of immunoglobulin M and A in autoimmune pancreatitis. J Gastroenterol 2009; 44(11): 1133-9.
38. Muraki T, Hamano H, Ochi Y, et al. Autoimmune pancreatitis and complement activation system. Pancreas 2006; 32(1): 16-21.
39. Takeda S, Haratake J, Kasai T, Takaeda C, Takazakura E. IgG4-associated idiopathic tubulointerstitial nephritis complicating autoimmune pancreatitis. Nephrol Dial Transplant 2004; 19(2): 474-6.
40. Saeki T, Saito A, Yamazaki H, et al. Tubulointerstitial nephritis associated with IgG4-related systemic disease. Clin Exp Nephrol 2007; 11(2): 168-73.
41. Farrell JJ, Garber J, Sahani D, Brugge WR. EUS findings in patients with autoimmune pancreatitis. Gastrointest Endosc 2004; 60(6): 927-36.
42. Kamisawa T, Tu Y, Nakajima H, et al. Sclerosing cholecystitis associated with autoimmune pancreatitis. World J Gastroenterol 2006; 12(23): 3736-9.
43. Irie H, Honda H, Baba S, et al. Autoimmune pancreatitis: CT and MR characteristics. AJR Am J Roentgenol 1998; 170(5): 1323-7.
44. Sahani D V, Kalva S P, Farrell J, et al. Autoimmune pancreatitis: imaging features. Radiology 2004; 233(2): 345-52.
45. Ichikawa T, Sou H, Araki T, et al. Duct-penetrating sign at MRCP: usefulness for differentiating inflammatory pancreatic mass from pancreatic carcinomas. Radiology 2001; 221(1): 107-16.
46. Wakabayashi T, Kawaura Y, Satomura Y, et al. Clinical and imaging features of autoimmune pancreatitis with focal pancreatic swelling or mass formation: comparison with so-called tumorforming pancreatitis and pancreatic carcinoma. Am J Gastroenterol 2003; 98(12): 2679-87.
47. Horiuchi A, Kawa S, Hamano H, Hayama M, Ota H, Kiyosawa K. ERCP features in 27 patients with autoimmune pancreatitis. Gastrointest Endosc 2002; 55(4): 494-9.
48. Nishino T, Oyama H, Hashimoto E, et al. Clinicopathological differentiation between sclerosing cholangitis with autoimmune pancreatitis and primary sclerosing cholangitis. J Gastroenterol 2007; 42(7): 550-9.
49. Nakazawa T, Ohara H, Sano H, et al. Difficulty in diagnosing autoimmune pancreatitis by imaging findings. Gastrointest Endosc 2007; 65(1): 99-108.
50. Horiuchi A, Kawa S, Akamatsu T, et al. Characteristic pancreatic duct appearance in autoimmune chronic pancreatitis: a case report and review of the Japanese literature. Am J Gastroenterol 1998; 93(2): 260-3.
51. Nakazawa T, Ohara H, Sano H, et al. Clinical differences between primary sclerosing cholangitis and sclerosing cholangitis with autoimmune pancreatitis. Pancreas 2005; 30(1): 20-5.
52. Nakazawa T, Ohara H, Sano H, et al. Cholangiography can discriminate sclerosing cholangitis with autoimmune pancreatitis from primary sclerosing cholangitis. Gastrointest Endosc 2004; 60(6): 937-44.
53. Nakazawa T, Ohara H, Sano H, Ando T, Joh T. Schematic classification of sclerosing cholangitis with autoimmune pancreatitis by cholangiography. Pancreas 2006; 32(2): 229.
54. Ando N, Yasuda I, Saito M, Moriwaki H. Hilar lymphadenopathy associated with autoimmune pancreatitis. Pancreas 2006; 33(1): 101-2.
55. Saeki T, Nishi S, Ito T, et al. Renal lesions in IgG4-related systemic disease. Intern Med 2007; 46(17): 1365-71.
56. Tsushima K, Tanabe T, Yamamoto H, et al. Pulmonary involvement of autoimmune pancreatitis. Eur J Clin Invest 2009; 39(8): 714-22.
57. Nakamoto Y, Sakahara H, Higashi T, et al. Autoimmune pancreatitis with F-18 fluoro-2-deoxy-D-glucose PET findings. Clin Nucl Med 1999; 24(10): 778-80.
58. Nakamoto Y, Saga T, Ishimori T, et al. FDG-PET of autoimmunerelated pancreatitis: preliminary results. Eur J Nucl Med 2000; 27(12): 1835-8.
59. Higashi T, Saga T, Nakamoto Y, et al. Diagnosis of pancreatic cancer using fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET)--usefulness and limitations in "clinical reality". Ann Nucl Med 2003; 17(4): 261-79.
60. Kanno A, Satoh K, Kimura K, et al. Autoimmune pancreatitis with hepatic inflammatory pseudotumor. Pancreas 2005; 31(4): 420-3.
61. Kawamura E, Habu D, Higashiyama S, et al. A case of sclerosing cholangitis with autoimmune pancreatitis evaluated by FDG-PET. Ann Nucl Med 2007; 21(4): 223-8.
62. Nakajo M, Jinnouchi S, Fukukura Y, Tanabe H, Tateno R. The efficacy of whole-body FDG-PET or PET/CT for autoimmune pancreatitis and associated extrapancreatic autoimmune lesions. Eur J Nucl Med Mol Imaging 2007; 34(12): 2088-95.
63. Nishimori I, Kohsaki T, Onishi S, et al. IgG4-related autoimmune prostatitis: two cases with or without autoimmune pancreatitis. Intern Med 2007; 46(24): 1983-9.
64. Otsuka H, Morita N, Yamashita K, Nishitani H. FDG-PET/CT findings of autoimmune pancreatitis associated with idiopathic retroperitoneal fibrosis. Ann Nucl Med 2007; 21(10): 593-6.
65. Uchida K, Satoi S, Miyoshi H, et al. Inflammatory pseudotumors of the pancreas and liver with infiltration of IgG4-positive plasma cells. Intern Med 2007; 46(17): 1409-12.
66. Kajiwara M, Kojima M, Konishi M, et al. Autoimmune pancreatitis with multifocal lesions. J Hepatobiliary Pancreat Surg 2008; 15(4): 449-52.
67. Ozaki Y, Oguchi K, Hamano H, et al. Differentiation of autoimmune pancreatitis from suspected pancreatic cancer by fluorine-18 fluorodeoxyglucose positron emission tomography. J Gastroenterol 2008; 43(2): 144-51.
68. Sato M, Okumura T, Shioyama Y, Imura J. Extrapancreatic F-18 FDG accumulation in autoimmune pancreatitis. Ann Nucl Med 2008; 22(3): 215-9.
69. Lee TY, Kim MH, Park do H, et al. Utility of 18F-FDG PET/CT for differentiation of autoimmune pancreatitis with atypical pancreatic imaging findings from pancreatic cancer. AJR Am J Roentgenol 2009; 193(2): 343-8.
70. Matsubayashi H, Furukawa H, Maeda A, et al. Usefulness of positron emission tomography in the evaluation of distribution and activity of systemic lesions associated with autoimmune pancreatitis. Pancreatology 2009; 9(5): 694-9.
71. Shigekawa M, Yamao K, Sawaki A, et al. Is (18)Ffluorodeoxyglucose positron emission tomography meaningful for estimating the efficacy of corticosteroid therapy in patients with autoimmune pancreatitis? J Hepatobiliary Pancreat Surg 2010; 17(3): 269-74.
72. Hardacre JM, Iacobuzio-Donahue CA, Sohn TA, et al. Results of pancreaticoduodenectomy for lymphoplasmacytic sclerosing pancreatitis. Ann Surg 2003; 237(6): 853-9.
73. Suda K, Takase M, Fukumura Y, Kashiwagi S. Pathology of autoimmune pancreatitis and tumor-forming pancreatitis. J Gastroenterol 2007; 42(Suppl 18): 22-7.
74. Kamisawa T, Tu Y, Nakajima H, Egawa N, Tsuruta K, Okamoto A. Usefulness of biopsying the major duodenal papilla to diagnose autoimmune pancreatitis: a prospective study using IgG4-immunostaining. World J Gastroenterol 2006; 12(13): 2031-3.
75. Zhang L, Notohara K, Levy MJ, Chari ST, Smyrk TC. IgG4-positive plasma cell infiltration in the diagnosis of autoimmune pancreatitis. Mod Pathol 2007; 20(1): 23-8.
76. Deshpande V, Chicano S, Finkelberg D, et al. Autoimmune pancreatitis: a systemic immune complex mediated disease. Am J Surg Pathol 2006; 30(12): 1537-45.
77. Suda K, Takase M, Fukumura Y, et al. Histopathologic characteristics of autoimmune pancreatitis based on comparison with chronic pancreatitis. Pancreas 2005; 30(4): 355-8.
78. Song MH, Kim MH, Jang SJ, et al. Comparison of histology and extracellular matrix between autoimmune and alcoholic chronic pancreatitis. Pancreas 2005; 30(3): 272-8.
79. Kim KP, Kim MH, Kim JC, Lee SS, Seo DW, Lee SK. Diagnostic criteria for autoimmune chronic pancreatitis revisited. World J Gastroenterol 2006; 12(16): 2487-96.
80. Kim MH, Kwon S. Diagnostic criteria for autoimmune chronic pancreatitis. J Gastroenterol 2007; 42(Suppl 18): 42-9.
81. Kwon S, Kim MH, Choi EK. The diagnostic criteria for autoimmune chronic pancreatitis: it is time to make a consensus. Pancreas 2007; 34(3): 279-86.
82. Chari ST, Smyrk TC, Levy MJ, et al. Diagnosis of autoimmune pancreatitis: the Mayo clinic experience. Clin Gastroenterol Hepatol 2006; 4(8): 1010-6.
83. Pearson RK, Longnecker DS, Chari ST, et al. Controversies in clinical pancreatology: autoimmune pancreatitis: does it exist? Pancreas 2003; 27(1): 1-13.
84. Abraham SC, Wilentz RE, Yeo CJ, et al. Pancreaticoduodenectomy (Whipple resections) in patients without malignancy: are they all 'chronic pancreatitis'? Am J Surg Pathol 2003; 27(1): 110-20.
85. Weber SM, Cubukcu-Dimopulo O, Palesty JA, et al. Lymphoplasmacytic sclerosing pancreatitis: inflammatory mimic of pancreatic carcinoma. J Gastrointest Surg 2003; 7(1): 129-37.
86. Okazaki K, Kawa S, Kamisawa T, et al. Japanese clinical guidelines for autoimmune pancreatitis. Pancreas 2009; 38(8): 849-56.
87. Komatsu K, Hamano H, Ochi Y, et al. High prevalence of hypothyroidism in patients with autoimmune pancreatitis. Dig Dis Sci 2005; 50(6): 1052-7.
88. Chari ST, Smyrk TC, Levy MJ, et al. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol 2006; 4(8): 1010-6.
89. Ghazale A, Chari ST, Smyrk TC, et al. Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol 2007; 102(8): 1646-53.
90. Witkiewicz AK, Kennedy EP, Kennyon L, Yeo CJ, Hruban RH. Synchronous autoimmune pancreatitis and infiltrating pancreatic ductal adenocarcinoma: case report and review of the literature. Hum Pathol 2008; 39(10): 1548-51.
91. Motosugi U, Ichikawa T, Yamaguchi H, et al. Small invasive ductal adenocarcinoma of the pancreas associated with lymphoplasmacytic sclerosing pancreatitis. Pathol Int 2009; 59(10): 744-7.
92. Motoo Y, Minamoto T, Watanabe H, Sakai J, Okai T, Sawabu N. Sclerosing pancreatitis showing rapidly progressive changes with recurrent mass formation. Int J Pancreatol 1997; 21(1): 85-90.
93. Horiuchi A, Kaneko T, Yamamura N, et al. Autoimmune chronic pancreatitis simulating pancreatic lymphoma. Am J Gastroenterol 1996; 91(12): 2607-9.
94. Wakabayashi T, Motoo Y, Kojima Y, Makino H, Sawabu N. Chronic pancreatitis with diffuse irregular narrowing of the main pancreatic duct. Dig Dis Sci 1998; 43(11): 2415-25.
95. Uchida K, Okazaki K, Konishi Y, et al. Clinical analysis of autoimmune-related pancreatitis. Am J Gastroenterol 2000; 95(10): 2788-94.
96. Ectors N, Maillet B, Aerts R, et al. Non-alcoholic duct destructive chronic pancreatitis. Gut 1997; 41(2): 263-8.
97. Cavallini G. Is chronic pancreatitis a primary disease of the pancreatic ducts? A new pathogenetic hypothesis. Ital J Gastroenterol 1993; 25(7): 391-6.
98. Frulloni L, Bovo P, Di Francesco V, Cavallini G, Zamboni G. "Non-alcoholic duct destructive chronic pancreatitis" or "primary chronic pancreatitis"? Gut 1999; 44(4): 579.
99. Chari ST. Diagnosis of autoimmune pancreatitis using its five cardinal features: introducing the Mayo Clinic's HISORt criteria. J Gastroenterol 2007; 42(Suppl 18): 39-41.
100. Otsuki M, Chung JB, Okazaki K, et al. Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea symposium on autoimmune pancreatitis. J Gastroenterol 2008; 43(6): 403-8.
101. Park DH, Kim MHD, Chari ST. Recent advances in autoimmune pancreatitis. Gut 2009; 58(12):1680-9.
102. Takayama M, Hamano H, Ochi Y, et al. Recurrent attacks of autoimmune pancreatitis result in pancreatic stone formation. Am J Gastroenterol 2004; 99(5): 932-7.
103. Nakano S, Takeda I, Kitamura K, Watahiki H, Iinuma Y, Takenaka M. Vanishing tumor of the abdomen in patient with Sjogren's syndrome. Am J Dig Dis 1978; 23(Suppl): 75-9S.
104. Ito T, Nishimori I, Inoue N, et al. Treatment for autoimmune pancreatitis: consensus on the treatment for patients with autoimmune pancreatitis in Japan. J Gastroenterol 2007; 42(Suppl 18): 50-8.
105. Kamisawa T, Shimosegawa T, Okazaki K, et al. Standard steroid treatment for autoimmune pancreatitis. Gut 2009; 58(11): 1504-7.
106. Nishino T, Toki F, Oyama H, Shimizu K, Shiratori K. Long-term outcome of autoimmune pancreatitis after oral prednisolone therapy. Intern Med 2006; 45(8): 497-501.
107. Saito T, Tanaka S, Yoshida H, et al. A case of autoimmune pancreatitis responding to steroid therapy. Evidence of histologic recovery. Pancreatology 2002; 2(6): 550-6.
108. Matsushita M, Yamashina M, Ikeura T, et al. Effective steroid pulse therapy for the biliary stenosis caused by autoimmune pancreatitis. Am J Gastroenterol 2007; 102(1): 220-1.
109. Church NI, Pereira SP, Deheragoda MG, et al. Autoimmune pancreatitis: clinical and radiological features and objective response to steroid therapy in a UK series. Am J Gastroenterol 2007; 102(11): 2417-25.
110. Nijs J, Macken E, Struyf N, Gys T, Bergmans G, Pelckmans P. Autoimmune pancreatitis with evolution to cholangitis: a case report. Acta Gastroenterol Belg 2004; 67(4): 346-50.
111. Sandanayake NS, Church NI, Chapman MH, et al. Presentation and management of post-treatment relapse in autoimmune pancreatitis/immunoglobulin G4-associated cholangitis. Clin Gastroenterol Hepatol 2009; 7(10): 1089-96.
112. Raina A, Yadav D, Krasinskas AM, et al. Evaluation and management of autoimmune pancreatitis: experience at a large US center. Am J Gastroenterol 2009; 104(9): 2295-306.
113. Ghazale A, Chari ST, Zhang L, et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology 2008; 134(3): 706-15.
114. Matsushita M, Ikeura T, Fukui T, Uchida K, Okazaki K. Refractory autoimmune pancreatitis: azathioprine or steroid pulse therapy? Am J Gastroenterol 2008; 103(7): 1834-5.
115. Topazian M, Witzig TE, Smyrk TC, et al. Rituximab therapy for refractory biliary strictures in immunoglobulin G4-associated cholangitis. Clin Gastroenterol Hepatol 2008; 6(3): 364-6.
116. Kamisawa T, Okamoto A. Prognosis of autoimmune pancreatitis. J Gastroenterol 2007; 42(Suppl 18): 59-62.
117. Kawa S, Hamano H, Kiyosawa K. High serum IgG4 concentrations in patients with sclerosing pancreatitis reply. N Engl J Med 2001; 345(2): 148.
118. Choi EK, Kim MH, Lee TY, et al. The sensitivity and specificity of serum immunoglobulin G and immunoglobulin G4 levels in the diagnosis of autoimmune chronic pancreatitis: Korean experience. Pancreas 2007; 35(2): 156-61.
119. Kawa S, Hamano H, Ozaki Y, et al. Long-term follow-up of autoimmune pancreatitis: characteristics of chronic disease and recurrence. Clin Gastroenterol Hepatol 2009; 7(11 Suppl): S18-22.
120. Park do H, Kim MH, Oh HB, et al. Substitution of aspartic acid at position 57 of the DQbeta1 affects relapse of autoimmune pancreatitis. Gastroenterology 2008; 134(2): 440-6.
121. Umemura T, Ota M, Hamano H, et al. Association of autoimmune pancreatitis with cytotoxic T-lymphocyte antigen 4 gene polymorphisms in Japanese patients. Am J Gastroenterol 2008; 103(3): 588-94.
122. Kubota K, Iida H, Fujisawa T, et al. Clinical factors predictive of spontaneous remission or relapse in cases of autoimmune pancreatitis. Gastrointest Endosc 2007; 66(6): 1142-51.
123. Kim T, Grobmyer SR, Dixon LR, Allan RW, Hochwald SN. Autoimmune pancreatitis and concurrent small lymphocytic lymphoma: not just a coincidence? J Gastrointest Surg 2008; 12(9): 1566-70.
124. Oh HC, Kim JG, Kim JW, et al. Early bile duct cancer in a background of sclerosing cholangitis and autoimmune pancreatitis. Intern Med 2008; 47(23): 2025-8.
125. Takahashi N, Ghazale AH, Smyrk TC, Mandrekar JN, Chari ST. Possible association between IgG4-associated systemic disease with or without autoimmune pancreatitis and non-Hodgkin lymphoma. Pancreas 2009; 38(5): 523-6.
126. Sato Y, Takata K, Ichimura K, et al. IgG4-producing marginal zone B-cell lymphoma. Int J Hematol 2008; 88(4): 428-33.
127. Cheuk W, Yuen HK, Chan AC, et al. Ocular adnexal lymphoma associated with IgG4+ chronic sclerosing dacryoadenitis: a previously undescribed complication of IgG4-related sclerosing disease. Am J Surg Pathol 2008; 32(8): 1159-67.
128. Sato Y, Ohshima K, Ichimura K, et al. Ocular adnexal IgG4-related disease has uniform clinicopathology. Pathol Int 2008; 58(8): 465-70.
129. Inoue H, Miyatani H, Sawada Y, Yoshida Y. A case of pancreas cancer with autoimmune pancreatitis. Pancreas 2006; 33(2): 208-9.
130. Ghazale A, Chari S. Is autoimmune pancreatitis a risk factor for pancreatic cancer? Pancreas 2007; 35(4): 376.
131. Fukui T, Mitsuyama T, Takaoka M, Uchida K, Matsushita M, Okazaki K. Pancreatic cancer associated with autoimmune pancreatitis in remission. Intern Med 2008; 47(3): 151-5.
132. Lowenfels AB, Maisonneuve P, Cavallini G, et al. Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N Engl J Med 1993; 328(20): 1433-7.
133. Kamisawa T, Horiguchi SI, Hayashi Y, et al. K-ras mutation in the major duodenal papilla and gastric and colonic mucosa in patients with autoimmune pancreatitis. J Gastroenterol 2010; 45(7): 771-8.
134. Aalberse RC, Van Milligen F, Tan KY, Stapel SO. Allergenspecific IgG4 in atopic disease. Allergy 1993; 48(8): 559-69.
135. Ottesen EA, Skvaril F, Tripathy SP, Poindexter RW, Hussain R. Prominence of IgG4 in the IgG antibody response to human filariasis. J Immunol 1985; 134(4): 2707-12.
136. Rock B, Martins CR, Theofilopoulos AN, et al. The pathogenic effect of IgG4 autoantibodies in endemic pemphigus foliaceus (fogo selvagem). N Engl J Med 1989; 320(22): 1463-9.
137. Aoki S, Nakazawa T, Ohara H, et al. Immunohistochemical study of autoimmune pancreatitis using anti-IgG4 antibody and patients' sera. Histopathology 2005; 47(2): 147-58.
138. van der Neut Kolfschoten M, Schuurman J, Losen M, et al. Antiinflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange. Science 2007; 317(5844): 1554-7.
139. Kawa S, Kitahara K, Hamano H, et al. A novel immunoglobulinimmunoglobulin interaction in autoimmunity. PLoS One 2008; 3(2): e1637.
140. Rispens T, Ooievaar-De Heer P, Vermeulen E, Schuurman J, van der Neut Kolfschoten M, Aalberse RC. Human IgG4 binds to IgG4 and conformationally altered IgG1 via Fc-Fc interactions. J Immunol 2009; 182(7): 4275-81.
141. Okazaki K, Uchida K, Ohana M, et al. Autoimmune-related pancreatitis is associated with autoantibodies and a Th1/Th2-type cellular immune response. Gastroenterology 2000; 118(3): 573-81.
142. Uchida K, Okazaki K, Nishi T, et al. Experimental immunemediated pancreatitis in neonatally thymectomized mice immunized with carbonic anhydrase II and lactoferrin. Lab Invest 2002; 82(4): 411-24.
143. Guarneri F, Guarneri C, Benvenga S. Helicobacter pylori and autoimmune pancreatitis: role of carbonic anhydrase via molecular mimicry? J Cell Mol Med 2005; 9(3): 741-4.
144. Kawa S, Ota M, Yoshizawa K, et al. HLA DRB1*0405-DQB1*0401 haplotype is associated with autoimmune pancreatitis in the Japanese population. Gastroenterology 2002; 122(5): 1264-9.
145. Asada M, Nishio A, Uchida K, et al. Identification of a novel autoantibody against pancreatic secretory trypsin inhibitor in patients with autoimmune pancreatitis. Pancreas 2006; 33(1): 20-6.
146. Endo T, Takizawa S, Tanaka S, et al. Amylase alpha-2A autoantibodies: novel marker of autoimmune pancreatitis and fulminant type 1 diabetes. Diabetes 2009; 58(3): 732-7.
147. Takizawa S, Endo T, Wanjia X, Tanaka S, Takahashi M, Kobayashi T. HSP 10 is a new autoantigen in both autoimmune pancreatitis and fulminant type 1 diabetes. Biochem Biophys Res Commun 2009; 386(1): 192-6.
148. Frulloni L, Lunardi C, Simone R, et al. Identification of a novel antibody associated with autoimmune pancreatitis. N Engl J Med 2009; 361(22): 2135-42.
149. Ota M, Katsuyama Y, Hamano H, et al. Two critical genes (HLADRB1 and ABCF1) in the HLA region are associated with the susceptibility to autoimmune pancreatitis. Immunogenetics 2007; 59(1): 45-52.
150. Freitag T, Cham C, Sung HH, et al. The human risk allele HLADRB1*0405 predisposes class II transgenic Ab0 NOD mice to autoimmune pancreatitis. Gastroenterology 2010; 139(1): 281-91.
151. Umemura T, Ota M, Hamano H, Katsuyama Y, Kiyosawa K, Kawa S. Genetic association of Fc receptor-like 3 polymorphisms with autoimmune pancreatitis in Japanese patients. Gut 2006; 55(9): 1367-8.
152. Hirano K, Asaoka Y, Tada M, et al. No significant relation between relapse of autoimmune pancreatitis and substitution of aspartic acid at position 57 of DQbeta1. J Gastroenterol 2009; 44(7): 799-800.
153. Kochi Y, Yamada R, Suzuki A, et al. A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities. Nat Genet 2005; 37(5): 478-85.
154. Gough SC, Walker LS, Sansom DM. CTLA4 gene polymorphism and autoimmunity. Immunol Rev 2005; 204: 102-15.
155. Chang MC, Chang YT, Tien YW, et al. T-cell regulatory gene CTLA-4 polymorphism/haplotype association with autoimmune pancreatitis. Clin Chem 2007; 53(9): 1700-5.
156. Umemura T, Katsuyama Y, Hamano H, et al. Association analysis of Toll-like receptor 4 polymorphisms with autoimmune pancreatitis. Hum Immunol 2009; 70(9): 742-6.
157. Taniguchi T, Hamasaki A, Okamoto M. A case of suspected lymphocytic hypophysitis and organizing pneumonia during maintenance therapy for autoimmune pancreatitis associated with autoimmune thrombocytopenia. Endocr J 2006; 53(4): 563-6.
158. Matsuda M, Hamano H, Yoshida T, et al. Seronegative Sjogren syndrome with asymptomatic autoimmune sclerosing pancreatitis. Clin Rheumatol 2007; 26(1): 117-9.
159. Kamisawa T, Tu Y, Sasaki R, Egawa N, Kamata N, Sasaki T. The relationship of salivary gland function to elevated serum IgG4 in autoimmune pancreatitis. Intern Med 2007; 46(8): 435-9.
160. Li Y, Bai Y, Liu Z, et al. Immunohistochemistry of IgG4 can help subclassify Hashimoto's autoimmune thyroiditis. Pathol Int 2009; 59(9): 636-41.
161. Duvic C, Desrame J, Leveque C, Nedelec G. Retroperitoneal fibrosis, sclerosing pancreatitis and bronchiolitis obliterans with organizing pneumonia. Nephrol Dial Transplant 2004; 19(9): 2397-9.
162. Kobayashi H, Shimokawaji T, Kanoh S, Motoyoshi K, Aida S. IgG4-positive pulmonary disease. J Thorac Imaging 2007; 22(4): 360-2.
163. Ito M, Yasuo M, Yamamoto H, et al. Central airway stenosis in a patient with autoimmune pancreatitis. Eur Respir J 2009; 33(3): 680-3.
164. Tsuboi H, Inokuma S, Setoguchi K, et al. Inflammatory pseudotumors in multiple organs associated with elevated serum IgG4 level: recovery by only a small replacement dose of steroid. Intern Med 2008; 47(12): 1139-42.
165. Zen Y, Kitagawa S, Minato H, et al. IgG4-positive plasma cells in inflammatory pseudotumor (plasma cell granuloma) of the lung. Hum Pathol 2005; 36(7): 710-7.
166. Shinji A, Sano K, Hamano H, et al. Autoimmune pancreatitis is closely associated with gastric ulcer presenting with abundant IgG4-bearing plasma cell infiltration. Gastrointest Endosc 2004; 59(4): 506-11.
167. Chang MC, Chang YT, Wei SC, Kuo CH, Liang PC, Wong JM. Autoimmune pancreatitis associated with high prevalence of gastric ulcer independent of Helicobacter pylori infection status. Pancreas 2009; 38(4): 442-6.
168. Unno H, Saegusa H, Fukushima M, Hamano H. Usefulness of endoscopic observation of the main duodenal papilla in the diagnosis of sclerosing pancreatitis. Gastrointest Endosc 2002; 56(6): 880-4.
169. Kubota K, Iida H, Fujisawa T, et al. Clinical significance of swollen duodenal papilla in autoimmune pancreatitis. Pancreas 2007; 35(4): e51-60.
170. Kuroiwa T, Suda T, Takahashi T, et al. Bile duct involvement in a case of autoimmune pancreatitis successfully treated with an oral steroid. Dig Dis Sci 2002; 47(8): 1810-6.
171. Kojima E, Kimura K, Noda Y, Kobayashi G, Itoh K, Fujita N. Autoimmune pancreatitis and multiple bile duct strictures treated effectively with steroid. J Gastroenterol 2003; 38(6): 603-7.
172. Zen Y, Harada K, Sasaki M, et al. IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis? Am J Surg Pathol 2004; 28(9): 1193-203.
173. Mendes FD, Jorgensen R, Keach J, et al. Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis. Am J Gastroenterol 2006; 101(9): 2070-5.
174. Hamano H, Umemura T, Uehara T, Kawa S, Kiyosawa K. IgG4-related sclerosing cholangitis should be included as an exclusion criterion for the diagnosis of primary sclerosing cholangitis. Am J Gastroenterol 2007; 102(3): 691-2.
175. Umemura T, Zen Y, Hamano H, Kawa S, Nakanuma Y, Kiyosawa K. Immunoglobin G4-hepatopathy: association of immunoglobin G4-bearing plasma cells in liver with autoimmune pancreatitis. Hepatology 2007; 46(2): 463-71.
176. Umemura T, Zen Y, Hamano H, et al. IgG4 associated autoimmune hepatitis: a differential diagnosis for classical autoimmune hepatitis. Gut 2007; 56(10): 1471-2.
177. Uchiyama-Tanaka Y, Mori Y, Kimura T, et al. Acute tubulointerstitial nephritis associated with autoimmune-related pancreatitis. Am J Kidney Dis 2004; 43(3): e18-25.
178. Saeki T, Saito A, Hiura T, et al. Lymphoplasmacytic infiltration of multiple organs with immunoreactivity for IgG4: IgG4-related systemic disease. Intern Med 2006; 45(3): 163-7.
179. Rudmik L, Trpkov K, Nash C, et al. Autoimmune pancreatitis associated with renal lesions mimicking metastatic tumours. CMAJ 2006; 175(4): 367-9.
180. Cornell LD, Chicano SL, Deshpande V, et al. Pseudotumors due to IgG4 immune-complex tubulointerstitial nephritis associated with autoimmune pancreatocentric disease. Am J Surg Pathol 2007; 31(10): 1586-97.
181. Yoneda K, Murata K, Katayama K, et al. Tubulointerstitial nephritis associated with IgG4-related autoimmune disease. Am J Kidney Dis 2007; 50(3): 455-62.
182. Takahashi N, Kawashima A, Fletcher JG, Chari ST. Renal involvement in patients with autoimmune pancreatitis: CT and MR imaging findings. Radiology 2007; 242(3): 791-801.
183. Khalili K, Doyle DJ, Chawla TP, Hanbidge AE. Renal cortical lesions in patients with autoimmune pancreatitis: a clue to differentiation from pancreatic malignancy. Eur J Radiol 2008; 67(2): 329-35.
184. Uchida K, Okazaki K, Asada M, et al. Case of chronic pancreatitis involving an autoimmune mechanism that extended to retroperitoneal fibrosis. Pancreas 2003; 26(1): 92-4.
185. Fukukura Y, Fujiyoshi F, Nakamura F, Hamada H, Nakajo M. Autoimmune pancreatitis associated with idiopathic retroperitoneal fibrosis. AJR Am J Roentgenol 2003; 181(4): 993-5.
186. Kamisawa T, Matsukawa M, Ohkawa M. Autoimmune pancreatitis associated with retroperitoneal fibrosis. JOP 2005; 6(3): 260-3.
187. Miyajima N, Koike H, Kawaguchi M, Zen Y, Takahashi K, Hara N. Idiopathic retroperitoneal fibrosis associated with IgG4-positive-plasmacyte infiltrations and idiopathic chronic pancreatitis. Int J Urol 2006; 13(11): 1442-4.
188. Kuwatani M, Kawakami H, Makiyama H, et al. Autoimmune pancreatitis with retroperitoneal fibrosis which responded to steroid therapy but was complicated with refractory renal dysfunction. Intern Med 2007; 46(18): 1557-64.
189. Ito H, Kaizaki Y, Noda Y, Fujii S, Yamamoto S. IgG4-related inflammatory abdominal aortic aneurysm associated with autoimmune pancreatitis. Pathol Int 2008; 58(7): 421-6.
190. Yoshimura Y, Takeda S, Ieki Y, Takazakura E, Koizumi H, Takagawa K. IgG4-associated prostatitis complicating autoimmune pancreatitis. Intern Med 2006; 45(15): 897-901.
191. Uehara T, Hamano H, Kawakami M, et al. Autoimmune pancreatitis-associated prostatitis: distinct clinicopathological entity. Pathol Int 2008; 58(2): 118-25.
192. Nakamura A, Funatomi H, Katagiri A, et al. A case of autoimmune pancreatitis complicated with immune thrombocytopenia during maintenance therapy with prednisolone. Dig Dis Sci 2003; 48(10): 1968-71.
193. Murase K, Matsunaga T, Hayashi T, et al. Successful treatment of autoimmune pancreatitis complicated with autoimmune thrombocytopenia and interstitial pneumonia by prednisolone. Intern Med 2008; 47(11): 1033-8.
194. Otsuki M. Chronic pancreatitis. The problems of diagnostic criteria. Pancreatology 2004; 4(1): 28-41.
195. Choi EK, Kim MH, Kim JC, et al. The Japanese diagnostic criteria for autoimmune chronic pancreatitis: is it completely satisfactory? Pancreas 2006; 33(1): 13-9.
196. Kim KP, Kim MH, Song MH, Lee SS, Seo DW, Lee SK. Autoimmune chronic pancreatitis. Am J Gastroenterol 2004; 99(8): 1605-16.
197. Finkelberg DL, Sahani D, Deshpande V, Brugge WR. Autoimmune pancreatitis. N Engl J Med 2006; 355(25): 2670-6.
198. Pickartz T, Mayerle J, Lerch MM. Autoimmune pancreatitis. Nat Clin Pract Gastroenterol Hepatol 2007; 4(6): 314-23.
199. Kloppel G, Luttges J, Lohr M, Zamboni G, Longnecker D. Autoimmune pancreatitis: pathological, clinical, and immunological features. Pancreas 2003; 27(1): 14-9.
200. Kamisawa T, Chung JB, Irie H, et al. Japan-Korea symposium on autoimmune pancreatitis (KOKURA 2007). Pancreas 2007; 35(3): 281-4.
201. Park S, Chung J, Otsuki M, et al. Conference report: Korea-Japan symposium on autoimmne pancreatitis. Gut Liver 2008; 2: 81-7.
202. Chari ST, Takahashi N, Levy MJ, et al. A diagnostic strategy to distinguish autoimmune pancreatitis From pancreatic cancer. Clin Gastroenterol Hepatol 2009; 7(10): 1097-103.
203. Sah RP, Chari ST, Pannala R, et al. Differences in clinical profile and relapse rate of type 1 vs type 2 autoimmune pancreatitis. Gastroenterology 2010; 139(1): 281-91.
204. Moon SH, Kim MH, Park DH, et al. Is a 2-week steroid trial after initial negative investigation for malignancy useful in differentiating autoimmune pancreatitis from pancreatic cancer? A prospective outcome study. Gut 2008; 57(12): 1704-12.